Shuo Yuan

Annual review of PROTAC degraders as anticancer agents in 2022

Xiao Wang, Zhao-Long Qin, Na Li et al. · European Journal of Medicinal Chemistry · 2024 · 91 citations · Full text

Tumor Biology, Chemoprevention Strategy, Medicine +8

Discovery of New 4-Indolyl Quinazoline Derivatives as Highly Potent and Orally Bioavailable P-Glycoprotein Inhibitors

Shuo Yuan, Bo Wang, Qing-Qing Dai et al. · Journal of Medicinal Chemistry · 2021 · 55 citations · Full text

Bioactive Diterpenoids from the Stems of <i>Euphorbia royleana</i>

Peixia Wang, Chunfeng Xie, Lijun An et al. · Journal of Natural Products · 2019 · 40 citations

LncRNA ANRIL promotes multiple myeloma progression and bortezomib resistance by EZH2-mediated epigenetically silencing of PTEN

Lihui Yang, Peng Du, Wei Liu et al. · Neoplasma · 2021 · 33 citations · Full text

Lncrna Anril, Immunology, Epigenetics +17

Brønsted acid-promoted ‘on–water’ C(sp3)-H functionalization for the synthesis of isoindolinone/[1,2,4]triazolo[1,5-a]pyrimidine derivatives targeting the SKP2-CKS1 interaction

Shuo Yuan, Sixi Wang, Min Zhao et al. · Chinese Chemical Letters · 2019 · 30 citations

Skp2-cks1 Interaction, Biochemistry, Natural Sciences +6